Dr. Viraj Nevrekar

Dr. Viraj Nevrekar is a Senior Consultant in Medical Oncology and Hemato-Oncology with over 11 years of dedicated clinical experience in treating complex and advanced cancers. A graduate of the All India Institute of Medical Sciences (AIIMS), New Delhi — one of India's most respected medical institutions — he holds both an MD in Medicine and a DM in Medical Oncology, credentials that reflect his rigorous training in oncological care. His additional ECMO certification from Switzerland underscores his commitment to staying at the forefront of global cancer treatment standards.

Dr. Nevrekar brings comprehensive clinical depth across all major oncology disciplines. His practice encompasses bone marrow transplantation, chemotherapy protocols, immunotherapy, targeted therapies, and hormone-based treatments for breast, prostate, and gynecologic malignancies. He manages high-volume patient cases and applies evidence-based clinical judgment to design personalized treatment plans for each patient, ensuring outcomes that balance efficacy with quality of life.

International patients — particularly those from the Gulf region, Africa, and Southeast Asia — choose Dr. Nevrekar for his patient-centric approach and clear communication across English, Hindi, and Marathi. He has established strong working relationships with leading corporate hospital networks and maintains alignment with international oncology literature, making him a trusted resource for patients seeking second opinions or comprehensive management of advanced disease.

Dr. Nevrekar practices at Gleneagles Global Hospitals in Mumbai's Parel neighborhood, a NABH-accredited facility known for its advanced oncology infrastructure, dedicated cancer care units, and seamless coordination for international patients. The hospital's robust support systems, multilingual staff, and comprehensive diagnostic capabilities make it an ideal destination for patients requiring specialized cancer treatment combined with the comfort of a world-class medical environment.

For international patients considering treatment in India, Dr. Nevrekar's combination of elite training, extensive clinical experience, and affordability — with consultation fees at just USD 65 — represents excellent value without compromise on clinical rigor or patient safety.